Skip to content

A Exploratory Study of NatureU Sweet Dream on Sleep Outcomes

A Single-Center, Open-Label, Exploratory Self-Controlled Study of NatureU Sweet Dream on Deep Sleep Duration and Deep Sleep Percentage in Adults With Sleep Disturbance

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07600528
Acronym
NUSD
Enrollment
17
Registered
2026-05-20
Start date
2024-04-15
Completion date
2024-04-17
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance, Sleep Quality

Keywords

NatureU Sweet Dream, sleep, deep sleep duration, deep sleep percentage, GABA, Lactium

Brief summary

This was a single-center, open-label, exploratory self-controlled study evaluating NatureU Sweet Dream on sleep outcomes in adults with mild to moderate sleep disturbance. Seventeen participants were enrolled, 2 participants were lost to follow-up, and 15 participants provided valid effectiveness data. Participants completed two independent test-food sessions using wearable sleep monitoring. The comparator session used a commercially available melatonin product, and the test-product session used NatureU Sweet Dream. The main outcomes were deep sleep duration and deep sleep percentage measured by a wearable device and exported through the Huawei Health application. No adverse reactions were reported during the study.

Detailed description

The study evaluated the effect of NatureU Sweet Dream, an oral functional food product containing GABA and Lactium, on sleep outcomes. During the screening period, study staff explained the study procedures, product intake method, and wearable monitoring method, and participants signed informed consent before enrollment. Participants were issued a Huawei Band 8 wearable device and the study product. Participants maintained normal diet and routines, avoided alcohol, and used the wearable device for sleep monitoring. In each independent test-food session, participants avoided excessive exercise 2 hours before sleep, took the assigned product with warm water 1 hour before sleep, turned off light sources before sleep, and exported sleep monitoring data the next morning from the Huawei Health application. Study enrollment started on April 15, 2024. Primary completion and last follow-up occurred on April 17, 2024. This exploratory study had no blinding and was intended to generate preliminary within-participant evidence for sleep-related outcomes.

Interventions

DIETARY_SUPPLEMENTNatureU Sweet Dream

NatureU Sweet Dream is an oral functional food product containing GABA and Lactium. Participants took the product with warm water 1 hour before sleep during the test-product session.

DIETARY_SUPPLEMENTCommercially Available Melatonin Product

The comparator was a commercially available melatonin product taken during the comparator session.

Sponsors

OmniSolutions Laboratory Holdings Limited
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Masking description

The study was open-label with no masking.

Intervention model description

Participants completed two independent test-food sessions: one comparator session with a commercially available melatonin product and one test-product session with NatureU Sweet Dream.

Eligibility

Sex/Gender
ALL
Age
18 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent before the study and understood the study content, procedures, and possible adverse reactions. * Adult participant with mild to moderate sleep disturbance. * Able and willing to use the wearable sleep monitoring device according to study instructions. * Able to maintain normal diet and routine habits during the study. * Able to avoid alcohol during the study period. * Able to avoid excessive exercise 2 hours before sleep during test nights. * Able to take the assigned product with warm water 1 hour before sleep during test nights. * Willing to complete the full study procedures and provide sleep monitoring data.

Exclusion criteria

* Known allergy or hypersensitivity to the study product, comparator product, or any related ingredients. * Severe sleep disorder or other condition judged by the investigator to make participation inappropriate. * Acute or chronic illness that could affect sleep assessment or participant safety. * Use of medications, supplements, or procedures that could affect sleep outcomes during the study period. * Alcohol intake or other behavior likely to interfere with sleep testing. * Inability to use the wearable monitoring device or mobile application as required. * Serious protocol deviation or inability to tolerate the test food. * Any factor that could seriously affect study results. * Any other reason judged by the investigator to require withdrawal or exclusion.

Design outcomes

Primary

MeasureTime frameDescription
Difference in Deep Sleep Duration Between NatureU Sweet Dream and Comparator Product24 hoursDeep sleep duration in minutes was measured using the Huawei Band 8 wearable device and exported from the Huawei Health application after each test-food session. The primary endpoint was the difference in deep sleep duration after NatureU Sweet Dream compared with the commercially available melatonin product.

Secondary

MeasureTime frameDescription
Difference in Deep Sleep Percentage Between NatureU Sweet Dream and Comparator Product24 hoursDeep sleep percentage was measured using the Huawei Band 8 wearable device and exported from the Huawei Health application after each test-food session. The secondary endpoint was the difference in deep sleep percentage after NatureU Sweet Dream compared with the commercially available melatonin product.

Countries

China

Contacts

STUDY_DIRECTORLuke Law, Dr

OmniSolutions Laboratory Holdings Limited

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026